PillRx only · Injection, Solution · Subcutaneous
Romosozumab-Aqqg
Brands: Evenity · Romosozumab
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
7.1K
Rx · 2026 Q1
16K
Units dispensed
-6%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Amgen, Inc | unknown | 3 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 21, 2025RECALLRecall (Class II): EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use Only, Rx Only, Manufactured by: Amgen Inc.,…
CGMP Deviations; potential temperature excursions due to transit delays — Recalling firm: Mckesson Medical-Surgical Inc. Corporate Office — Within the U.S - OH, VA, FL.